126
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , , , ORCID Icon, , , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2467-2476 | Published online: 13 Oct 2020

References

  • VestboJ, PrescottE, LangeP. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996;153(5):1530–1535. doi:10.1164/ajrccm.153.5.86305978630597
  • GuerraS, SherrillDL, VenkerC, CeccatoCM, HalonenM, MartinezFD. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax. 2009;64(10):894–900. doi:10.1136/thx.2008.11061919581277
  • DotanY, SoJY, Chronic BronchitisKV. Where Are We Now? Chronic Obstr Pulm Dis. 2019;6:178–192.31063274
  • KimV, HanMK, VanceGB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011;140(3):626–633. doi:10.1378/chest.10-294821474571
  • AgustiA, CalverleyPM, CelliB, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122. doi:10.1186/1465-9921-11-12220831787
  • ManninoDM, BuistAS, PettyTL, EnrightPL, ReddSC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58(5):388–393. doi:10.1136/thorax.58.5.38812728157
  • PrescottE, LangeP, VestboJ. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J. 1995;8(8):1333–1338. doi:10.1183/09031936.95.080813337489800
  • ManninoDM, DohertyDE, BuistAS. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med. 2006;100:115–122.15893923
  • FletcherCM, PrideNB. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax. 1984;39(2):81–85. doi:10.1136/thx.39.2.816701830
  • KimV, CrapoJ, ZhaoH, et al. Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc. 2015;12(3):332–339. doi:10.1513/AnnalsATS.201411-518OC25575351
  • KimV, ZhaoH, ReganE, et al. The St. George’s Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition. Chest. 2019;156(4):685–695. doi:10.1016/j.chest.2019.03.04131047955
  • JonesPW, HardingG, BerryP, WiklundI, ChenWH, Kline LeidyN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
  • JonesPW, BrusselleG, Dal NegroRW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35. doi:10.1183/09031936.0017721021565915
  • CouperD, LavangeLM, HanM, et al. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax. 2014;69(5):491–494. doi:10.1136/thoraxjnl-2013-203897
  • FerrisBG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis. 1978;118::1–120.
  • MeguroM, BarleyEA, SpencerS, JonesPW. Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest. 2007;132(2):456–463. doi:10.1378/chest.06-070217646240
  • VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
  • WassersteinRLN, LazarNA. The ASA Statement on p -values: context, Process, and Purpose. Am Stat. 2016;70(2):129–133. doi:10.1080/00031305.2016.1154108
  • HarringtonD, D’AgostinoRB, GatsonisC. New Guidelines for Statistical Reporting in the Journal. N Engl J Med. 2019;381(3):285–286. doi:10.1056/NEJMe190655931314974
  • MchughML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22:276–282.23092060
  • AndersonWH, HaJW, CouperDJ, et al. Variability in objective and subjective measures affects baseline values in studies of patients with COPD. PLoS One. 2017;12(9):e0184606. doi:10.1371/journal.pone.018460628934249
  • HanMK, QuibreraPM, CarrettaEE, et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(8):619–626. doi:10.1016/S2213-2600(17)30207-228668356
  • HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
  • MullerovaH, DransfieldMT, ThomashowB, et al. Clinical Development and Research Applications of the COPD Assessment Test (CAT). Am J Respir Crit Care Med. 2019. doi:10.1164/rccm.201907-1369PP.
  • RingbaekT, MartinezG, LangeP. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD. 2012;9(1):12–15. doi:10.3109/15412555.2011.63024822292593
  • RassouliF, BatyF, StolzD, et al. Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk. Int J Chron Obstruct Pulmon Dis. 2017;12:3103–3109. doi:10.2147/COPD.S14164629123387
  • BhattSP, PatelSB, AndersonEM, et al. Video Telehealth Pulmonary Rehabilitation Intervention in Chronic Obstructive Pulmonary Disease Reduces 30-Day Readmissions. Am J Respir Crit Care Med. 2019;200(4):511–513. doi:10.1164/rccm.201902-0314LE30978302